EFFECTIVENESS IN HUMANS OF AN ANTIVIRAL DRUG BASED ON CHOLINERGIC AGONISTS WITH SPECIFIC DESIGN AND ROUTE OF ADMINISTRATION AGAINST COVID-19 SYMPTOMS IN A GROUP OF INFECTED PATIENTS VS. CONTROL GROUP
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.